Park Square has placed Clare Murray, Ph.D. as Chief Executive Officer at EnPlusOne Biosciences.
| less than a minute read
EnPlusOne Biosciences Appoints Clare Murray, Ph.D. as CEO
EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced the appointment of Clare Murray, Ph.D., as Chief Executive Officer.

/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-01-21-26-53-841-6a97431d406533fea8d4615c.gif)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-01-15-07-30-357-6a96ea32ce35c90f7ee74028.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-24-14-26-15-201-6a8c5487b4553f6e28c0bcb7.jpg)
/Passle/58a5cb8db00e8110e83aa395/SearchServiceImages/2026-08-19-20-29-57-758-6a8612450e2b381c3863fcf2.jpg)